Q3 2025 Tenet Healthcare Corp Earnings Call Transcript
Key Points
- Tenet Healthcare Corp (THC) reported strong financial performance with third quarter 2025 net operating revenues of $5.3 billion and a 12% year-over-year growth in consolidated adjusted EBITDA to $1.1 billion.
- The company achieved an adjusted EBITDA margin of 20.8%, a 170 basis points improvement over the prior year, driven by strong same-store growth and continued operating efficiency.
- USPI, a segment of THC, generated $492 million in adjusted EBITDA, representing a 12% growth year-over-year, with same-facility revenues growing by 8.3%.
- THC raised its full-year 2025 adjusted EBITDA guidance to a range of $4.47 billion to $4.57 billion, reflecting confidence in its business performance.
- The company reported strong free cash flow generation, with $778 million in the third quarter and $2.16 billion year-to-date, up 22% over the same period in the prior year.
- Uncertainty remains regarding the enhanced premium tax subsidies and their impact on reimbursement and enrollment in exchanges for 2026.
- THC faces potential challenges with state-directed payment programs for 2026, as approvals for increases are still pending.
- The company noted a slight increase in exchange admissions, which could indicate potential pressure on revenue if exchange subsidies expire.
- THC's hospital segment experienced lower-than-expected respiratory and infectious disease volumes, which may signal a slower start to the respiratory season.
- The company faces ongoing inflationary pressures, particularly related to tariffs, which require careful management and optimization efforts.
Good morning, welcome to Tenet Healthcare's third quarter 2025 earnings conference call. (Operator Instructions)
I'll now turn the call over to your host, Mr. Will McDowell, Vice President of Investor Relations. Mr. McDowell, you may begin.
Good morning, everyone, and thank you for joining today's call. I am Will McDowell, Vice President of Investor Relations. We're pleased to have you join us for a discussion of Tenet's third quarter 2025 results as well as a discussion of our financial outlook. Tenant senior management participating in today's call will be Dr. Saum Sutaria, Chairman and Chief Executive Officer; and Sun Park, Executive Vice President and Chief Financial Officer.
Our webcast this morning includes a slide presentation, which has been posted to the Investor Relations section of our website, tenethealth.com. Listeners to this call are advised that certain statements made during our discussion today are forward-looking and represent management's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

